Daratumumab in Treating Transplant-Eligible Patients With Multiple Myeloma
Mayo Clinic
Mayo Clinic
Wake Forest University Health Sciences
Celgene
Memorial Sloan Kettering Cancer Center
Massachusetts General Hospital
GPCR Therapeutics, Inc.
Pfizer
National Institutes of Health Clinical Center (CC)
University Hospital, Lille
Medical College of Wisconsin
University of Chicago
University of Chicago
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
Pfizer
Thomas Jefferson University
University Hospital, Lille
Institut Curie
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
Brown University
GWT-TUD GmbH
Memorial Sloan Kettering Cancer Center
Mayo Clinic
Amgen
GlaxoSmithKline
Masonic Cancer Center, University of Minnesota
Emory University
Mayo Clinic
Celgene
Mayo Clinic
Masonic Cancer Center, University of Minnesota
Memorial Sloan Kettering Cancer Center
Celgene
Rapa Therapeutics LLC
M.D. Anderson Cancer Center
University of Michigan Rogel Cancer Center
Thomas Jefferson University
Thomas Jefferson University
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Scientific Affairs, LLC
Thomas Jefferson University
TJ Biopharma Co., Ltd.
Universitätsklinikum Hamburg-Eppendorf
M.D. Anderson Cancer Center
Takeda
Fred Hutchinson Cancer Center
Arbeitsgemeinschaft medikamentoese Tumortherapie
Insel Gruppe AG, University Hospital Bern